Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Perez-Garcia JM, Llombart-Cussac A, G Cortes M, Curigliano G, Lopez-Miranda E, Alonso JL, Bermejo B, Calvo L, Caranana V, de la Cruz Sanchez S, M Vazquez R, Prat A, R Borrego M, Sampayo-Cordero M, Segui-Palmer MA, Soberino J, Malfettone A, Schmid P, Cortes J. Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial. Eur J Cancer. 2021 May;148:382-394. doi: 10.1016/j.ejca.2021.02.028. Epub 2021 Mar 29. PubMed PMID: 33794440.
AÑO: 2021; IF: 10.002
33794440
Gonzalez-Cao M, Mayo de Las Casas C, Oramas J, Berciano-Guerrero MA, de la Cruz L, Cerezuela P, Arance A, Munoz-Couselo E, Espinosa E, Puertolas T, Diaz Beveridge R, Ochenduszko S, Villanueva MJ, Basterretxea L, Bellido L, Rodriguez D, Campos B, Montagut C, Drozdowskyj A, Molina MA, Lopez-Martin JA, Berrocal A. Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial. Nat Commun. 2021 Dec 1;12(1):7008. doi: 10.1038/s41467-021-26572-6. PubMed PMID: 34853302; PubMed Central PMCID: PMC8636498.
AÑO: 2021; IF: 17.694
34853302
Albert-Mari A, Gil-Lemus M feminineA, Conde-Estevez D, San Jose-Ruiz B, Jimenez-Pulido I, Esteban-Mensua M feminineJ, Cercos-Lleti AC, Diaz-Carrasco M feminineS. Classification of antineoplastic drug-induced tissue damage: a Consensus of the Spanish Oncology Pharmacy Group. Farm Hosp. 2021 Jun 15;45(4):198-203. doi: 10.7399/fh.11625. PubMed PMID: 34218766.
AÑO: 2021
34218766
Escobar Alvarez, Y.; de las Penas Bataller, R.; Perez Altozano, J.; Ros Martinez, S.; Sabino Alvarez, A.; Blasco Cordellat, A.; Brozos Vazquez, E.; Corral Jaime, J.; Garcia Escobar, I.; Beato Zambrano, C.. SEOM clinical guidelines for anaemia treatment in cancer patients (2020) (vol 23, pg 931, 2021). CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(10):2192-2193. 10.1007/s12094-021-02681-y
AÑO: 2021; IF: 3.34
Jimenez-Labaig P, Pacheco-Barcia V, Cebria A, Galvez F, Obispo B, Paez D, Quilez A, Quintanar T, Ramchandani A, Remon J, Rogado J, Sanchez DA, Sanchez-Canovas M, Sanz-Garcia E, Sesma A, Tarazona N, Cotes A, Gonzalez E, Bosch-Barrera J, Fernandez A, Felip E, Vera R, Rodriguez-Lescure A, Elez E. Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM). ESMO Open. 2021 Aug;6(4):100215. doi: 10.1016/j.esmoop.2021.100215. Epub 2021 Jul 26. PubMed PMID: 34325108; PubMed Central PMCID: PMC8332651.
AÑO: 2021; IF: 6.883
34325108
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL